Mamoru Kanda - Concepedia

Author

Mamoru Kanda

Kyoto Pharmaceutical Industries (Japan)

Also Known As

M KANDA, M Kanda, M. KANDA, M. Kanda, MAMORU KANDA, Mamoru KANDA, Mamoru Kanda, Mayumi Kanda

Publications

501

Citations

H-Index

Concepts

All Affiliations

Kyoto Pharmaceutical Industries (Japan)Kyoto University The University of Tokyo Tokai University Kanazawa University

About

Mamoru Kanda is an author at Kyoto Pharmaceutical Industries (Japan) specializing in pharmacology, medicine, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	270
2	Engineering	2	2	48
3	Applied Physics	2	2	48
4	Health Sciences	1	1	17
5	Natural Sciences	1	1	29

Mamoru Kanda

Publications

389

Citations

H-Index

Page 1

	Year	Citations
Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice Yasue Sakaguchi, Hiroaki Shirahase, Atsuko Ichikawa, Life Sciences InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	2004	42
Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice—possible dysfunction of receptor and/or receptor–G protein coupling Tomohiro Miike, Kazuyoshi Kunishiro, Mamoru Kanda, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PhysiologyCardiovascular DiseaseMedicineVascular PharmacologyPhysiology	2008	36
Self-written waveguide on a VCSEL-emitting window using a photomask transfer method Yusuke Obata, Mamoru Kanda, Osamu Mikami IEEE Photonics Technology Letters PhotonicsEngineeringOptical PropertiesWavelength ConversionPhotomask Transfer Method	2006	33
Endothelium‐dependent contraction in intrapulmonary arteries: mediation by endothelial NK<sub>1</sub> receptors and TXA<sub>2</sub> Hiroaki Shirahase, Mamoru Kanda, Kazuyoshi Kurahashi, British Journal of Pharmacology ImmunologyCardiovascular PharmacologyPharmacotherapyEndothelium‐dependent ContractionRabbit Intrapulmonary Artery	1995	30
Synthesis and Biological Evaluation of (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: A Novel Series of PPAR.GAMMA. Agonists Satoru Azukizawa, Masayasu Kasai, Kenji Takahashi, Chemical and Pharmaceutical Bulletin Lipid PeroxidationPharmacotherapyExperimental PharmacologyMolecular PharmacologyPharmacological Study	2008	30
Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: Peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition Kazuya Otake, Satoru Azukizawa, Masaki Fukui, Bioorganic & Medicinal Chemistry BiochemistryMedicineNatural SciencesMechanism Of ActionReceptor (Biochemistry)	2011	29
Novel Indoline-Based Acyl-CoA:Cholesterol Acyltransferase Inhibitor with Antiperoxidative Activity: Improvement of Physicochemical Properties and Biological Activities by Introduction of Carboxylic Acid Kenji Takahashi, Masayasu Kasai, Masaru Ohta, Journal of Medicinal Chemistry Carboxylic AcidOxysterolBiochemistryMedicineLipid Peroxidation	2008	27
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice Yuma Ito, Masaki Fukui, Mamoru Kanda, Journal of Pharmacological Sciences	2018	21
Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats Yasue Sakaguchi, Hiroaki Shirahase, Kazuyoshi Kunishiro, Life Sciences InflammationReactive Nitrogen SpecieMedicinePhysiologyNitric Oxide Synthase	2006	20
Somatostatin-induced contraction mediated by endothelial TXA2 production in canine cerebral arteries Hiroaki Shirahase, Mamoru Kanda, Hisanobu Shimaji, Life Sciences Somatostatin-induced ContractionAngiogenesisCanine Cerebral ArteriesNeurophysiologyPhysiology	1993	17

Page 1